1. Solute Carrier Family 29A1 Mediates In Vitro Resistance to Azacitidine in Acute Myeloid Leukemia Cell Lines
   Monika M. Kutyna et al, 2023, International Journal of Molecular Sciences CrossRef
2. Modulation of the Endothelin System in Colorectal Cancer Liver Metastasis: Influence of Epigenetic Mechanisms?
   Mohamed R. Mahdi et al, 2020, Frontiers in Pharmacology CrossRef
3. Combination of azacytidine and curcumin is a potential alternative in decitabine-resistant colorectal cancer cells with attenuated deoxycytidine kinase
   Mika Hosokawa et al, 2021, Biochemical and Biophysical Research Communications CrossRef
4. Treatment effects of oxaliplatin combined with gemcitabine on colorectal cancer and its influence on HMGB1 expression
   Shuangshuang Wen et al, 2016, Oncology Letters CrossRef
5. Cell signaling and cancer: a mechanistic insight into drug resistance
   Munmun Panda et al, 2019, Molecular Biology Reports CrossRef
6. Treatment with decitabine induces the expression of stemness markers, PD-L1 and NY-ESO-1 in colorectal cancer: potential for combined chemoimmunotherapy
   Nassiba Taib et al, 2023, Journal of Translational Medicine CrossRef
7. In vitro assessment of a synergistic combination of gemcitabine and zebularine in pancreatic cancer cells
   Manali Patki et al, 2021, Experimental Cell Research CrossRef
8. Nucleosidic DNA demethylating epigenetic drugs – A comprehensive review from discovery to clinic
   Khushboo Agrawal et al, 2018, Pharmacology & Therapeutics CrossRef
9. Decitabine exerted synergistic effects with oxaliplatin in colorectal cancer cells with intrinsic resistance to decitabine
   Mika Hosokawa et al, 2019, Biochemical and Biophysical Research Communications CrossRef
10. HDAC2 Inhibitor Valproic Acid Increases Radiation Sensitivity of Drug-Resistant Melanoma Cells
    Bhuvanesh Sukhlal Kalal et al, 2019, Medical Sciences CrossRef
11. Mocetinostat combined with gemcitabine for the treatment of leiomyosarcoma: Preclinical correlates
    Gonzalo Lopez et al, 2017, PLOS ONE CrossRef
12. Different mechanisms of drug resistance to hypomethylating agents in the treatment of myelodysplastic syndromes and acute myeloid leukemia
    Kristína Šimoničová et al, 2022, Drug Resistance Updates CrossRef